MedPage Today on MSN
FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...
Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure ...
Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...
Sources from a University of Mississippi Press Release say that Liver cancer is the third-leading cause of cancer deaths ...
Doctors are reassessing decades of standard treatment for patients who have had heart attacks after new research shows ...
20hon MSN
Examining the long-term effects of common heartburn medications on kidney and cardiovascular health
A new study from Karolinska Institutet suggests that some widely used heartburn medications may be linked to kidney problems ...
When the human body gets hurt, most tissues heal—skin closes over a wound, bone heals itself. But not all organs heal that ...
In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.
A hormone called vasopressin is clearly better at saving the lives of patients whose hearts have stopped than the drug doctors have been using for the past 100 years, according to a study that could ...
Funded entirely by taxpayer dollars, this first-of-its-kind drug targets cellular metabolism to promote tissue repair of ...
News-Medical.Net on MSN
AI, omics, and systems biology could transform heart drug development
AI, omics, and systems biology can now help scientists design targeted drugs for cardiovascular disease pathways once thought ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results